Quick Takeaways
- Walters William T. filed SCHEDULE 13G/A for Zentalis Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (ZNTL).
- Disclosed ownership: 9.9%.
- Date of event: 29 Jan 2025.
Walters William T. - 29 Jan 2025 SCHEDULE 13G/A Report for Zentalis Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (ZNTL)
- Filing Manager
- Walters William T.
- Reporting Manager
- Walters William T
- Symbol
- ZNTL
- Shares outstanding
- 71,212,121 shares
- Disclosed Ownership
- 7,050,000 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 31 Jan 2025, 12:44:27 UTC
- Date of event
- 29 Jan 2025
- Previous filing
- 22 Jan 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Walters William T. disclosed 9.9% ownership in Zentalis Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (ZNTL) on 29 Jan 2025."
What Changed
- Previous schedule filing date: 22 Jan 2025.
- Current filing was accepted on 31 Jan 2025, 12:44.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Walters William T | 9.9% | 7,050,000 | 0 | 7,050,000 | William T. Walters | Individual | |
| WALTERS GROUP | 9.9% | 7,050,000 | 0 | 7,050,000 | Susan B. Walters | Susan B. Walters, General Partner | |
| Walters, Susan B. | 9.9% | 7,050,000 | 0 | 7,050,000 | Susan B. Walters | Individual |